This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Primary research
Yazhuo Zhang
Beijing Neurosurgical Institute
Corresponding Author
ORCiD: https://orcid.org/0000-0002-8583-2580
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background：
Pit-1 is a POU-homeodomain transcription factor, Cyclin-dependent kinase（CDK5）is a protein kinase that can phosphorylate many key transcription factors, but the mechanism of CDK5 phosphorylates Pit-1 is unclear.
Methods:
We generated an antibody that specifically recognizes phosphorylated serine at position 126 of Pit-1 (Ser126-Pit-1); we used western blotting to detect the level of Pit-1 phosphorylation and observed the proliferation and apoptosis of GH3 cells with different levels of Pit-1 phosphorylation by clone formation experiments, cell viability assays, and flow cytometry. ELISA was used to measure the level of PRL in the supernatant of GH3 cells. Tissue microarrays and immunohistochemistry were used to evaluate the expression of phosphorylation level of Ser126-Pit-1 (pSer126-Pit-1) in prolactinomas.
Results
Our data indicated that Ser126-Pit-1 is specifically phosphorylated by CDK5. pSer-126-Pit-1 can promote cell proliferation and PRL secretion. In addition, a higher level of pSer-126-Pit-1 correlates with a worse prognosis in patients with prolactinoma.
Conclusions
CDK5-mediated Ser126-Pit-1 phosphorylation regulates prolactinoma progression and PRL secretion.
Keywords
Pit-1, CDK5, prolactinoma, phosphorylation, proliferation
Figure 1
Figure 2
Figure 3
Figure 4
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
View the published article at Open Chemistry.
Version 1
Posted 11 Aug, 2020
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Cancer Biology
Learn more about our company.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Primary research
Yazhuo Zhang
Beijing Neurosurgical Institute
Corresponding Author
ORCiD: https://orcid.org/0000-0002-8583-2580
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
View the published article at Open Chemistry.
Version 1
Posted 11 Aug, 2020
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Cancer Biology
License:
This work is licensed under a CC BY 4.0 License. Read Full License
View the published article at Open Chemistry.
Background：
Pit-1 is a POU-homeodomain transcription factor, Cyclin-dependent kinase（CDK5）is a protein kinase that can phosphorylate many key transcription factors, but the mechanism of CDK5 phosphorylates Pit-1 is unclear.
Methods:
We generated an antibody that specifically recognizes phosphorylated serine at position 126 of Pit-1 (Ser126-Pit-1); we used western blotting to detect the level of Pit-1 phosphorylation and observed the proliferation and apoptosis of GH3 cells with different levels of Pit-1 phosphorylation by clone formation experiments, cell viability assays, and flow cytometry. ELISA was used to measure the level of PRL in the supernatant of GH3 cells. Tissue microarrays and immunohistochemistry were used to evaluate the expression of phosphorylation level of Ser126-Pit-1 (pSer126-Pit-1) in prolactinomas.
Results
Our data indicated that Ser126-Pit-1 is specifically phosphorylated by CDK5. pSer-126-Pit-1 can promote cell proliferation and PRL secretion. In addition, a higher level of pSer-126-Pit-1 correlates with a worse prognosis in patients with prolactinoma.
Conclusions
CDK5-mediated Ser126-Pit-1 phosphorylation regulates prolactinoma progression and PRL secretion.
Figure 1
Figure 2
Figure 3
Figure 4
Loading...